Alphabet’s cash outlay needs a commissioning test
Negative quarterly free cash flow makes the path from purchased capacity to useful output more important.
Featured
Previously pinned articles and homepage highlights.
Featured
AI cache performance should be measured inside its trust boundary
A useful inference benchmark must preserve the separation customers require, not just produce faster answers.
Hubitos.ai explained: product content and social publishing for small commerce teams
An examination of Hubitos’s product information, image and scripted video creation, social editing and scheduling, with practical checks for usable a…
MicroVision and on-sensor computing: where integration work moves
On-sensor computing changes the work of integrating and maintaining a machine, beyond reducing its hardware count.
Medical AI and the cost of obtaining the next answer
Evaluating diagnostic AI requires asking what information can actually be obtained, at what burden, and whether it changes care.
Rogers and the capital-spending cycle: what lower investment can and cannot tell us
Lower investment needs a service-outcome test before it can be read as lasting efficiency.
Before a market price becomes evidence
A market chart needs more than a number: its observation rule determines which claims the data can support.
Is the control group in an AI pilot really untouched by AI?
When agents change colleagues’ work, comparing licensed users with non-users can miss the organization’s actual gain.
Who stays after the match? Measuring streaming cohorts
Event-driven growth needs consistent cohorts, clear activation boundaries and enough time to observe renewal.
Who gets to wait when AI capacity is shared?
Shared AI capacity makes waiting a product decision, requiring clear deadlines, service classes and limits on priority.
Iambic and the Two Ledgers of AI Biotech
Financing and scientific evidence need separate accounts, even when they support the same research programme.
When a Price Service Changes, Who Can Still Exit?
Oracle migrations need separate decisions for opening risk, reducing exposure and reopening a market.